The SEC Management introduces the new look of corporate website www.sec.or.th, featuring multi-device accessibility as well as more user-friendly experience for the public, investors and regulated
resulted in reallocation between sales and service revenue as well as marketing expenses while device subsidy is capitalized as contract assets and amortized against the service revenue over the customer
meeting notice concerning the calculated impacts of the proposed capital increase on the shareholders, and the lack of clarity in the objectives of the capital increase. Since this case may affect the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
% YoY and 2% QoQ, comprising of service revenue and device sale as follows. Service revenue was Bt38,235mn increasing 5. 3% YoY and 3.5% QoQ. Excluding IC and equipment rental, core service revenue in
mobile market. On the cost side, there’s less marketing spending QoQ and lower tower & equipment rental from settling disputes with TOT. As a result, reported EBITDA was Bt21,135mn increasing 19% YoY and
as 2 dermatology and plastic surgery center to provide specialized services by the dermatologists and / or anti- aging. In addition the services and equipment are not differentiated; therefore, pricing
dermatology and plastic surgery center to provide specialized services by the dermatologists and / or anti- aging. In addition the services and equipment are not differentiated; therefore, pricing strategy is
hospitals and medical equipment that will support continuous growth momentum in demand for medical devices in Thailand. 4 Due to growth medical device business, the Company plans to develop new products as